Sustained release and activation of the growth factor basic fibroblast growth factor from loaded scaffolds in heart valve tissue engineering

References

• Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Molecular biology of the cell4th ed. Garland Science, New York, NY 2002
   Google Scholar
• Albes JM, Klenzner T, Kotzerke J, Thiedelmann KU, Schafers HJ, Borst HG. Improvement of tracheal autograft revascularisation by means of fibroblast growth factor. Ann Thorac Surg 1994; 57: 444–449
   PubMed Web of Science ®Google Scholar
• Balzarotti M, Fontana F, Marras C, Boiardi A, Croci D, Ciusani E, Salmaggi A. In vitro study of low molecular weight heparin effect on cell growth and cell invasion in primary cell cultures of high-grade gliomas. Oncol Res 2006; 16(5)245–250
   Google Scholar
• Bernfield M, Götte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 1999; 68: 729–777
   PubMed Web of Science ®Google Scholar
• Edelman E, Mathiowitz E, Langer R, Klagsbrun M. Controlled and modulated release of basic fibroblast growth factor. Biomaterials 1991; 12: 619–626
   PubMed Web of Science ®Google Scholar
• Ferrans VJ, Spray TL, Billingham ME, Roberts WC. Structural changes in glutaraldehyde treated porcine heterografts used as substitute heart valves: Transmission and scanning electron microscopic observations in 17 patients. Am J Cardiol 1978; 41: 1159–1184
   PubMed Web of Science ®Google Scholar
• Flaumenhaft R, Moscatelli D, Rifkin DB. Heparin and heparan sulfate increase the radius of diffusion and action of basic fibroblast growth factor. J Cell Biol 1990; 111: 1651–1659
   PubMed Web of Science ®Google Scholar
• Fujisato T, Sajiki T, Liu Q, Ikada Y. Effect of basic fibroblast growth factor on cartilage regeneration in chondrocyte-seeded collagen sponge scaffold. Biomaterials 1996; 17(2)155–162
   PubMed Web of Science ®Google Scholar
• Gallagher JT. Heparan sulfate: Growth control with a restricted sequence menu. J Clin Invest 2001; 108: 357–361
   PubMed Web of Science ®Google Scholar
• Gospodarowicz D, Cheng J. Heparin protects basic and acidic FGF from inactivation. J Cell Physiol 1986; 128(3)475–484
   PubMed Web of Science ®Google Scholar
• Hammermeister K, Sethi GK, Henderson WG. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: Final report of the veterans affairs randomised trial. J Am Coll Cardiol 2000; 36(4)1152–1158
   PubMed Web of Science ®Google Scholar
• Lai PH, Chang Y, Chen SC, Wang CC, Liang HC, Chang WC, Sung HW. Acellular biological tissues containing inherent GAGs for loading basic fibroblast growth factor promote angiogenesis and tissue regeneration. Tissue Eng 2006; 12(9)2499–2508
   Google Scholar
• Lane DA, Lindahl U. Highlights in the history of heparin. In heparin: Chemical and biological properties, clinical applications. CRC Press, Boca Raton, FL 1989; 1–23
   Google Scholar
• Lin X. Functions of heparan sulphate proteoglycans in cell signalling during development. Development 2004; 131(24)6009–6021
   Google Scholar
• Mareel MM, Bracke ME, Van Roy FM, De Baetselier P. Molecular mechanisms of cancer invasion. Encyclopedia of cancer, JR Bertino. Academic Press, San Diego, CA 1997; II: 1072–1083
   Google Scholar
• Marks MG, Doillon C, Silver FH. Effects of fibroblast and basic fibroblast growth factor on dermal wound healing by type I collagen matrices. J Biomed Mat Res 1991; 25: 683–696
   PubMed Web of Science ®Google Scholar
• Narine K, Claeys E, Cornelissen M, De Somer F, Beele H, Vanlangenhove L, De Smet S, Van Nooten G. Readily available porcine aortic matrices for use in tissue valve engineering. Is cryopreservation an option?. Cryobiology 2006; 53(2)169–181
   Google Scholar
• Narine K, Dewever O, Van Valckenborgh D, Francois K, Bracke M, De Smet S, Mareel M, Van Nooten G. Growth factor modulation of fibroblast proliferation, differentiation, and invasion: Implications for tissue valve engineering. Tissue Eng 2006; 12(10)2707–2716
   PubMedGoogle Scholar
• Perets A, Baruch Y, Weisbuch G, Shoshany G, Neufeld G, Cohen S. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release of basic fibroblast growth factor microspheres. J Biomed Mater Res 2003; 65A: 489–497
   Web of Science ®Google Scholar
• Steffens GCM, Yao C, Prevel P, Markowicz M, Schenck P, Noah EM, Pallua N. Modulation of angiogenic potential of collagen matrices by covalent incorporation of heparin and loading with vascular endothelial growth factor. Tissue Eng 2004; 10: 1502–1509
   PubMedGoogle Scholar
• Sweeney SM, Guy CA, Fields GB, San Antonio JD. Defining the domains of type I collagen involved in heparin-binding and endothelial tube formation. Proc Natl Acad Sci 1998; 95(13)7275–7280, USA
   Google Scholar
• Tae G, Scatena M, Stayton PS, Hoffman AS. PEG-cross-linked heparin is an affinity hydrogel for sustained release of vascular endothelial growth factor. J Biomater Sci Polym Ed 2006; 17(1–2)187–197
   PubMed Web of Science ®Google Scholar
• Taipale J, Keski-Oja J. Growth factors in the extracellular matrix. FASEB J 1997; 11: 51–59
   PubMed Web of Science ®Google Scholar
• Wang XH, Li DP, Wang WJ, Feng QL, Cui FZ, Xu YX, Song XH. Covalent immobilization of chitosan and heparin on PLGA surface. Int J Biol Macromol 2003; 33: 95–100
   PubMed Web of Science ®Google Scholar
• Wilson GJ, Courtman DW, Klement Peter, Lee JM, Yeger H. Acellular matrix: A biomaterials approach for coronary artery bypass and heart valve replacement. Ann Thorac Surg 1995; 60: 353–358
   PubMed Web of Science ®Google Scholar
• Yayon A, Klagsbrun M, Esko J, Leder P, Ornitz D. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991; 64: 841–848
   PubMed Web of Science ®Google Scholar
• Zeltinger J, Landeen LK, Alexander HG, Kidd IG, Sibanda B. Development and characterisation of tissue-engineered aortic valves. Tissue Eng 2001; 7(1)9–22
   Google Scholar